NR3C2 and congestive heart failure: Indeed, the benefit of MR blockade in patients with chronic heart failure and reduced ejection fraction was demonstrated in multiple clinical studies, which has become the basis for the recommendation of the use of MR antagonists in chronic heart failure [43,44,45].